Savage Sheri, serving as CFO across two companies, has filed 50 Form 4 transactions that paint a uniformly one-sided picture: she has not recorded a single open-market purchase or acquisition of shares, while her total sell value stands at roughly $2.54 million. The entirety of her recent activity, spanning 24 sell transactions, occurred on a single day—June 4, 2026—and was concentrated exclusively in Ultra Clean Holdings (UCTT). Those sales were executed in a rapid series of 24 separate filings, with individual values ranging from a modest $1,835.60 to a substantial $155,228.94, reflecting a deliberate liquidation of a large position rather than a single block trade.
The pattern in UCTT is striking for its density and lack of offsetting buys. There were no compensatory grants (code A), option exercises (code M), or tax-withholding events (code F) in the recent window—only open-market sales (code S). The only other transaction in the period was a July 1, 2026 grant of zero value in Itron (ITRI), which is a compensation award, not a conviction purchase. Across her entire filing history, Savage has never bought shares on the open market, meaning her $2.54 million in sales represents a pure reduction of her equity stake with no reinvestment signal.
The concentration of 24 sales in one day suggests a systematic unwinding, but the filings themselves offer no insight into motive. What is clear from the data is a strong sell bias: every discretionary transaction she has made was a sale, and the most recent cluster in UCTT dwarfs any other activity. For investors tracking insider behavior, the absence of any buy-side activity—coupled with the sheer volume of June 4 sales—marks Savage as a consistent net seller, with no recent indication of a shift toward accumulation.
AI-assisted summary